CJ Bio Indonesia

Overview

CJ Bio Indonesia represents a transformative investment in Southeast Asia’s bioplastics capacity and technology advancement, operating the region’s most sophisticated polyhydroxyalkanoate (PHA) production facility. Established as a subsidiary of South Korea’s CJ CheilJedang, a global leader in biochemistry and biopolymers, CJ Bio Indonesia commercialized its Pasuruan facility in May 2022 with an initial 5,000 metric ton annual capacity focused on amorphous PHA production.

The facility represents the culmination of CJ’s decades-long commitment to advanced biopolymer development, building on technology acquired from Metabolix in 2016 and refined through continuous innovation. With ambitious capacity expansion plans targeting 65,000 MT by 2025 and ultimately 300,000 MT by 2030, CJ Bio Indonesia positions itself as a critical enabler of Southeast Asia’s transition toward advanced biodegradable materials and circular economy development.

The company’s focus on amorphous PHA—a softer, more rubbery form of polyhydroxyalkanoate—differentiates its product portfolio and enables applications distinct from crystalline or semi-crystalline PHA forms, providing customers with diverse performance characteristics for specialized and emerging bioplastic applications.

Company Background and Strategic Positioning

CJ Bio Indonesia exists as part of CJ CheilJedang’s global biopolymer operations, representing the company’s strategic commitment to Southeast Asian bioplastics market development and its integration into broader South Korean biotechnology and bioplastics strategies.

CJ CheilJedang and BiopolymerExpertise

Parent Company Background:

CJ CheilJedang is a major South Korean multinational in biochemistry, biopolymers, and life sciences
Established leader in biodegradable polymer technology and commercialization
Global presence across Americas, Asia, and Europe
Advanced R&D capabilities and manufacturing expertise
Commitment to sustainable materials innovation

Biopolymer Heritage:

Acquisition of Metabolix biopolymer assets in 2016 marked strategic entry into PHA production
Metabolix pioneered PHA commercialization in the early 2000s
CJ invested in technology refinement and capacity expansion
Development of amorphous PHA as specialized product for diverse applications
Global manufacturing network supporting regional markets

Indonesia Investment Rationale

Strategic Location:

Southeast Asia represents fastest-growing bioplastics market globally
Indonesia serves as regional manufacturing and logistics hub
Pasuruan location provides accessibility to regional markets and supply chains
Government incentives supporting bioplastics manufacturing
Proximity to major customer base and distribution networks

Market Opportunity:

Rapidly expanding bioplastics demand across Southeast Asia
Regulatory pressures driving bioplastics adoption
Growing brand and consumer preference for sustainable materials
Government support for plastic reduction and bioplastics development
Integration with broader Asian biopolymer value chains

Technical Advantages:

Advanced PHA technology from CJ’s global research and development
Access to refined fermentation and polymerization processes
Quality systems and manufacturing excellence
Technical support and customer collaboration capabilities
Continuous innovation and process improvement

Polyhydroxyalkanoate (PHA) Technology Platform

CJ Bio Indonesia specializes in PHA production, focusing particularly on amorphous PHA formulations that offer distinct performance characteristics and application opportunities compared to alternative PHA forms.

PHA Chemistry and Production

Fundamental Characteristics:

Linear polyesters produced through natural bacterial fermentation
Biologically synthesized from renewable feedstocks (sugars, lipids)
Complete biodegradability in composting and environmental conditions
Fully renewable material without fossil fuel inputs
Performance envelope distinct from conventional and other bioplastics

Natural Production Process:

Bacteria ferment sugars and organic compounds into polymer structures
Metabolic accumulation of PHA as intracellular storage granules
Natural polymerization during microbial growth and metabolism
Extraction and purification of accumulated polymer
Processing into usable materials through controlled synthesis

Key Advantages:

Completely renewable feedstock sourcing
Natural biodegradation without synthetic catalysts
Absence of chemical residues and toxins
Carbon-neutral production supporting climate objectives
Integration with agricultural and waste valorization systems

Amorphous PHA Specialization

Distinction from Crystalline Forms:

Amorphous PHA exhibits lower glass transition temperature (Tg)
Softer, more rubbery material properties vs. crystalline forms
Enhanced flexibility and elongation vs. brittle crystalline variants
Distinct performance envelope enabling specialized applications
Complementary to semi-crystalline PHA for diverse market segments

Performance Characteristics:

Superior flexibility and strain tolerance
Enhanced processability in diverse manufacturing equipment
Lower processing temperatures vs. crystalline PHA
Improved film-forming characteristics
Suitable for thin-film and flexible packaging applications

Processing Advantages:

Compatibility with conventional plastic processing equipment
Lower energy input for material processing
Reduced processing temperatures limiting degradation
Extended processing window and equipment flexibility
Conventional machinery compatibility reducing customer investment

Feedstock Integration

Renewable Feedstock Sourcing:

Sugars and organic compounds from agricultural production
Lipids and fats from oil processing and waste streams
Agricultural residues and processing byproducts
Industrial fermentation substrates and waste valorization
Carbon-neutral feedstock integration where applicable

Supply Chain Advantages:

Southeast Asian agricultural abundance supporting feedstock availability
Integration with existing agricultural and processing infrastructure
Cost-competitive feedstock sourcing
Supply security through diverse feedstock sources
Support for agricultural waste valorization and circular economy

Production Facility and Capacity Development

CJ Bio Indonesia operates a state-of-the-art fermentation and polymerization facility in Pasuruan, East Java, representing one of Southeast Asia’s most advanced biopolymer manufacturing operations.

Pasuruan Facility Overview

Location and Significance:

Pasuruan, East Java, Indonesia—strategically located manufacturing hub
Accessible to regional markets and customer bases
Integration with regional chemical and petrochemical infrastructure
Proximity to feedstock suppliers and agricultural resources
Logistics and distribution network connectivity

Facility Infrastructure:

Advanced fermentation systems for PHA accumulation
Bacterial cultivation and growth optimization capabilities
Polymer extraction and purification equipment
Post-processing and material finishing systems
Quality assurance laboratories and testing infrastructure
Environmental monitoring and compliance systems
Warehousing and logistics coordination

Operational Capacity:

Current rated capacity: 5,000 metric tons per year
Amorphous PHA production exclusively
Continuous operation capability
High-purity product output
Multi-product line flexibility
Production consistency and quality assurance

Commercialization Timeline

2022 Launch:

Facility officially inaugurated in May 2022
First commercial shipments commenced in April 2022
Smooth transition from construction to full production
Achievement of design capacity within initial year
Customer qualification and market introduction

Operational History:

4+ years of proven operational success (2022-2026)
Consistent production performance and reliability
Quality consistency and product validation
Customer satisfaction and relationship development
Demonstration of scaling feasibility

Capacity Expansion Plans

Near-Term Expansion (2025-2026):

Capacity expansion to 65,000 MT/year anticipated
Additional production lines or facility expansion
Enhanced feedstock processing capabilities
Advanced quality and process control systems
Support for growing market demand

Long-Term Strategy (2026-2030):

Ambitious expansion to 300,000 MT/year
Multiple production facilities or significant enlargement
Geographic expansion within Southeast Asia
Support for global bioplastics growth
Establishment as region’s leading PHA producer

Scaling Infrastructure:

Expansion of fermentation capacity
Advanced process optimization and automation
Feedstock supply chain scaling
Logistics and distribution network expansion
Environmental and compliance infrastructure enhancement

Market Segments and Applications

CJ Bio Indonesia serves diverse market segments leveraging amorphous PHA’s unique performance characteristics and environmental benefits.

Flexible Packaging Applications

Thin-Film Packaging:

Single-use film packaging for food and consumer products
Compostable film alternatives for food service
Protective packaging and product wrapping
Agricultural and horticultural packaging
Specialty flexible packaging applications

Food Contact Packaging:

Food service packaging and disposables
Takeout containers and food wrapping
Food-contact compliance certifications
Beverage packaging applications
Specialized food packaging requirements

Consumer Goods Packaging:

Personal care product packaging
Cosmetic and household product packaging
Retail packaging and product protection
Brand-specific packaging solutions
Customized packaging applications

Advanced Applications

Marine Degradation:

Ocean-degradable packaging materials
Marine environment applications
Aquatic environment compatibility
Specialized biodegradation performance
Support for marine protection initiatives

Specialty Bioplastics:

Engineering applications and components
Automotive and industrial uses
Specialty formulations for specific requirements
High-performance biopolymer applications
Integration with advanced manufacturing

Market Geographic Scope

Southeast Asian Markets:

Primary regional focus for capacity and distribution
Rapidly growing bioplastics adoption
Support for regional regulatory compliance
Regional customer relationship development
Integration with Southeast Asian supply chains

Asia-Pacific Expansion:

Broader Asian market penetration
Support for regional bioplastics growth
Integration with Asian customer bases
Logistics and distribution network expansion

Global Markets:

Export capability to international customers
Support for global sustainability commitments
Integration with worldwide bioplastics value chains
International regulatory compliance

Industry Position and Competitive Strategy

CJ Bio Indonesia occupies a unique position in Southeast Asia’s bioplastics landscape as the region’s most advanced PHA producer with superior technology and substantial backing.

Regional Leadership

Southeast Asian Position:

Largest PHA production capacity in Southeast Asia
Most advanced fermentation and manufacturing technology
Superior product quality and consistency
Global parent company support and resources
Demonstrated operational excellence and reliability

Global Biopolymer Network:

Integration with CJ’s global PHA operations
Access to worldwide R&D and innovation
Global customer relationships and market access
Technology refinement and continuous improvement
International regulatory expertise and compliance

Competitive Advantages

Technology Excellence:

Decades of PHA development expertise inherited from parent company
Advanced fermentation systems and process control
Continuous process optimization and innovation capability
Quality systems and manufacturing excellence
Technical support and customer collaboration

Amorphous PHA Specialization:

Unique focus on amorphous PHA vs. crystalline alternatives
Distinct performance characteristics enabling specialized applications
Processing advantages for film and flexible packaging
Differentiated product offering vs. other PHA producers
Innovation in amorphous PHA applications and formulations

Financial Strength:

CJ CheilJedang parent company backing and resources
Capital availability for expansion and investment
Long-term strategic commitment to bioplastics
Financial stability supporting customer confidence
Investment in research and development

Supply Chain Integration:

Southeast Asian feedstock availability
Logistics and regional distribution infrastructure
Integration with regional petrochemical and processing industries
Scalable supplier relationships and sourcing
Cost-competitive manufacturing and distribution

Certifications and Environmental Compliance

CJ Bio Indonesia’s products meet stringent environmental and quality standards, supporting market acceptance and customer confidence in biodegradability and performance claims.

Biodegradability Certifications

Industrial Composting:

Compliance with international composting standards (EN 13432 equivalent)
Verified degradation in industrial composting conditions
Complete decomposition to biomass, CO₂, and water
Third-party testing and certification
Support for industrial composting infrastructure development

Marine Environment:

Testing for marine degradation performance
Compliance with marine environment standards where applicable
Reduced persistence in aquatic environments
Support for ocean protection objectives
Specialized marine degradation applications

Quality and Performance Standards

ISO Certifications:

ISO 9001 quality management system
Environmental management system compliance
Process control and quality assurance throughout operations
Continuous improvement and certification maintenance

Food Contact Compliance:

Food contact approvals and certifications where applicable
Regulatory compliance in major market jurisdictions
Safety and toxicity verification
Quality assurance in food-related applications

Sustainability and Environmental Benefits

CJ Bio Indonesia’s PHA production and products provide fundamental environmental advantages, supporting circular economy objectives and sustainable material transitions.

Complete Biodegradability and Degradation

Industrial Composting:

Complete biodegradation in industrial composting conditions
Conversion to biomass, CO₂, and water through microbial action
Full decomposition without persistence or accumulation
Timeline compatible with composting system operation
Support for industrial composting infrastructure development

Marine Environment:

Enhanced degradation in marine environments vs. conventional plastics
Reduced persistence in aquatic systems
Support for ocean plastic pollution reduction
Compatibility with marine ecosystem recovery
Differentiation vs. conventional and many bioplastic alternatives

Landfill and Soil Conditions:

Biodegradation in diverse environmental contexts
Decomposition in soil environments
Reduced accumulation in landfills vs. conventional plastics
Soil-compatible degradation products
Support for diverse environmental scenarios

Renewable Feedstock Benefits

Carbon Neutrality and Reduction:

Complete renewable feedstock sourcing
Significant lifecycle carbon reduction vs. petroleum plastics
Carbon-neutral or carbon-negative production potential
Climate change mitigation support
Avoided fossil fuel extraction and processing emissions

Agricultural Integration:

Feedstock sourcing from renewable agricultural production
Support for agricultural waste valorization
Integration with circular bioeconomy
Agricultural and industrial waste utilization
Economic support for agricultural communities

Circular Economy Integration:

Complete environmental biodegradation enabling circular nutrient cycling
Integration with composting infrastructure
Support for waste reduction and material reuse
Elimination of long-lived environmental pollutants
Closed-loop economic participation

Strategic Partnerships and Market Development

CJ Bio Indonesia leverages strategic partnerships and customer relationships supporting market growth and technology advancement.

Parent Company Integration

CJ CheilJedang Support:

Global R&D and technology support
International market and customer access
Financial and capital resources
Technical expertise and process optimization
Global supply chain integration

Customer Partnerships

Packaging manufacturers and converters
Brand companies seeking sustainable packaging alternatives
Food service and beverage industry customers
Specialty and advanced bioplastics application developers
Regional and international distribution partners

Industry Collaborations

Participation in bioplastics industry associations and standards development
Academic and research institution partnerships
Technology licensing and technical support
Standards development and industry best practices
Support for government sustainable materials initiatives

Financial Profile and Business Model

CJ Bio Indonesia operates as a subsidiary of CJ CheilJedang with a production-focused business model and demonstrated profitability pathway.

Business Model

B2B Manufacturing:

Production and sale of PHA biopolymer materials
Customer relationships with packaging manufacturers and brands
Technical support and material specifications
Custom formulation and specialized products
Integration with customer supply chains

Revenue Streams:

Biopolymer material sales to packaging and industrial customers
Specialty formulation premium pricing
Volume-based sales growth
Technical support and consultation services
Export sales expansion as capacity increases

Financial Structure

Corporate Backing:

CJ CheilJedang parent company ownership and support
Substantial capital resources for expansion
Financial stability and credit access
Long-term strategic commitment
Investment in R&D and continuous improvement

Growth Investment:

Significant capital deployed for facility development
Expansion funding for 65,000 MT and 300,000 MT capacity targets
Process technology and innovation investment
Supply chain development and optimization
Market development and customer relationship building

Future Outlook and Growth Strategy

CJ Bio Indonesia is positioned for substantial growth as Southeast Asia’s leading PHA biopolymer producer, supporting regional and global transitions toward advanced biodegradable materials.

Capacity Expansion Trajectory (2026-2030)

Immediate Expansion (2025-2026):

Scaling to 65,000 MT/year capacity
Additional fermentation and processing equipment
Enhanced feedstock sourcing and supply chain
Expanded quality and process control systems
Support for growing regional demand

Major Growth (2026-2030):

Expansion toward 300,000 MT/year target
Facility expansion or multiple production units
Geographic expansion within Southeast Asia
Advanced process technology and automation
Establishment as region’s dominant PHA producer

Market Development

Regional Growth:

Rapid expansion of Southeast Asian bioplastics market
Regulatory support and single-use plastic bans
Brand and corporate sustainability commitments
Growing consumer and institutional demand
Integration with regional circular economy initiatives

Application Expansion:

Development of new product formulations
Emerging applications and market segments
Specialty high-performance biopolymers
Integration with advanced manufacturing technologies
Support for innovative packaging and product solutions

Strategic Vision

CJ Bio Indonesia aspires to establish Southeast Asia’s preeminent position in advanced PHA biopolymer production and support a global transition toward biodegradable materials. Through continued investment in capacity, technology, and market development, the company will capture substantial growth in rapidly expanding Southeast Asian and international bioplastics markets. CJ Bio Indonesia’s success demonstrates the feasibility of advanced biopolymer manufacturing at scale within Southeast Asia and supports the region’s evolution toward sustainable materials, circular economy development, and environmental leadership.

Last updated: February 14, 2026

Sources: